메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

Health In Tech Announces New Davos 2026 Panel: "First Ladies: Backing Women Who Build" Featuring Cherie Blair CBE, KC

STUART, Fla., Nov. 5, 2025 -- Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, today announced an expansion of its agenda for the Independent InsurTech Summit to be held during World Economic Forum Week 2026 in Davos, Switzerland. Following the previously announced CEO panel, "AI and Institutional Resistance: CEOs Driving Change in Legacy Sectors," Health In Tech will host a second session titled "First Ladies: Backing Women Who Build." The panel will spotlight global leaders advancing women's ent
- 김갑성 기자
- 2025-11-05 07:48
Ispire Technology Inc. Schedules Fiscal First Quarter 2026 Earnings Conference Call

LOS ANGELES, Nov. 5, 2025 -- Ispire Technology Inc. ("Ispire" or the "Company") (NASDAQ: ISPR), a trailblazer in vaping technology and precision dosing, announced today that it will host its earnings conference call at 8:00 am ET on Thursday, November 6, 2025, to discuss the Company's financial results for its fiscal first quarter ended September 30, 2025. To listen to the conference call, please dial in using the information below. When prompted upon dialing-in, please ask for the "Ispire Technology Call." Date: Thursday, November 6, 2025 Time
- 황정호 기자
- 2025-11-05 05:06
INTREPID Alliance Launches Antiviral Toolbox to Support Global Research Community

Open-access resource includes Registry of Antiviral Compound Libraries to help catalyze drug discovery for priority viruses of pandemic and endemic concern CAMBRIDGE, Mass., Nov. 5, 2025 -- The INTREPID Alliance today announced the launch of the Antiviral Toolbox, an open-access resource to support the global research community in its efforts toward filling the gaps in antiviral R&D that is critical to global health security and the protection of communities worldwide. This curated platform provides easy access to a focused collection of tools and publications, including a
- 김갑성 기자
- 2025-11-05 02:20
IMG Announces Winner of First Student Journey Scholarship

INDIANAPOLIS, Nov. 4, 2025 -- IMG (International Medical Group) is excited to announce Susana Yeboah, a freshman nursing student at East Tennessee State University, as the winner of its inaugural Student Journey Scholarship. Launched earlier this year, the Student Journey Scholarship is designed to support international students pursuing higher education in the United States. Yeboah, a citizen of Ghana, will receive a $5,000 scholarship to help fund her academic journey as she works toward her dream of a life dedicated to caring for others. "This scholarship will ma
- 황정호 기자
- 2025-11-04 22:00
Metabolon Powers Largest-Ever Veteran Metabolomics Study with Global Discovery Panel

Metabolon to Support Landmark Million Veteran Program 62,000-sample Dataset Advancing Veteran Health and Multiomics Research MORRISVILLE, N.C., Nov. 4, 2025 -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, today announced that Metabolon's Global Discovery Panel, capable of identifying up to 5,400 annotated biochemicals in a biological sample, was selected to provide biomarker analysis for the Million Veteran Program's (MVP) 62,000
- 김갑성 기자
- 2025-11-04 22:00
Grit Biotherapeutics Invited to Deliver Oral Presentation at ASH 2025 on Breakthrough In Vivo CAR-T Therapy GT801

BEIJING, Nov. 4, 2025 -- Grit Biotherapeutics Co., Ltd. ("Grit Bio"), a leading clinical-stage biopharmaceutical company pioneering next-generation immunotherapies, today announced that its groundbreaking GT801 in vivo CAR-T program has been selected for an oral presentation at the upcoming 67th American Society of Hematology (ASH) Annual Meeting, to be held December 6–9, 2025, in Orlando, Florida, USA. The abstract, titled "Precision In Vivo CAR-T Generation via CLAMP-Enabled mRNA Delivery: Toward Scalable and Translatable Cell Therapy," was a
- 김갑성 기자
- 2025-11-04 21:15
LakeShore Biopharma Enters into Definitive Agreement for Going-Private Transaction

BEIJING, Nov. 4, 2025 -- LakeShore Biopharma Co., Ltd ("LakeShore Biopharma" or the "Company") (OTCPK: LSBCF; OTCPK: LSBWF), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that it has entered into an Agreement and Plan of Merger (the "Merger Agreement") with Oceanpine Skyline Inc. ("Parent") and Oceanpine Merger Sub Inc. ("Merger Sub"), a wholly owned subsidiary of Parent. Pursuant to
- 황정호 기자
- 2025-11-04 20:04
Sky Labs Attracts Investment With Omron Subsidiary 'OMRON VENTURES'

Global blood pressure monitoring No. 1 OMRON Healthcare signs strategic partnership MoU SEOUL, South Korea, Nov. 4, 2025 -- On November 4, 2025, Sky Labs announced that it had attracted investments with OMRON Ventures(OVC: Minato-ku, Tokyo), Omron Group's enterprise-led venture capital (CVC). This means strengthening strategic partnerships for global business expansion beyond simple financial investment. In addition, it has also signed a Memorandum of Understanding (MoU) with OMRON Healthcare Co., Ltd.(Head Office: Muko, Kyoto, President & CEO: Ayumu Okada) a
- 김갑성 기자
- 2025-11-04 19:25
Presented by OHKF, GIG, and Macao FoundationGlobal Bay Area Economic Forum 2025 Creating New Economic Momentum

HONG KONG, Nov. 4, 2025 -- The Global Bay Area Economic Forum 2025 hosted by Our Hong Kong Foundation (OHKF), The Guangzhou Institute of the Greater Bay Area (GIG), and Macao Foundation, draws on advanced experiences and practices from the economic development of major bay areas worldwide. It fully seizes opportunities in Bay Area economic growth, establishes a global dialogue platform for bay areas, leverages their unique advantages, better promotes the construction of the Guangdong-Hong Kong-Macao Greater Bay Area (GBA), and echos with the national "15th Five-Year Plan." The forum
- 김갑성 기자
- 2025-11-04 18:22
Elevaris Introduces CDMO Services, Procedural Needle Portfolio to EMEA

Company Leverages Legacy of Trust and Expertise as it Makes Inaugural Appearance at COMPAMED/MEDICA BOSTON, Nov. 4, 2025 -- Elevaris Medical Devices, the world-class Contract Development and Manufacturing Organization resulting from the acquisition of UK-based XL Precision Technologies by U.S.-based Spectra Medical Devices, is introducing its services and procedural needle portfolio to EMEA. The company is making its inaugural appearance at COMPAMED, the leading international trade fair for the medical technology supplier sector in Dusseldorf Nov. 17-20. "Elevaris M
- 김갑성 기자
- 2025-11-04 17:00

이전

51 52 53 54 55 56 57 58 59 60

많이 본 기사

최근기사

2026-01-01_THU

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 01월 01일 22시 40분